Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hematopoietic stem cell transplantation
Phenotype C0010346|crohn disease
Sentences 1
PubMedID- 20837778 We evaluated the safety and clinical outcome of autologous nonmyeloablative hematopoietic stem cell transplantation (hsct) in patients with severe crohn disease (cd) defined as a crohn disease activity index (cdai) greater than 250, and/or crohn severity index greater than 16 despite anti-tumor necrosis factor therapy.

Page: 1